+91-22-45045900 sales@clearsynth.com
Recent Updates
Meet Us at DCAT Week 2026, New York, Lotte New York Palace | Mar 23-26 | Room 1402
New Nitrosamine Compounds Now Available
Now Operating in San Diego, USA
Stable Isotopes Product Detail
Home Stable Isotopes CS-T-96997

N-Boc Deferoxamine-d7

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-96997 Stable Isotopes Research Use Only
N-Boc Deferoxamine-d7
Category
Stable Isotopes
API Family
--
Product Code
CS-T-96997
Research Status
For Laboratory Use

N-Boc Deferoxamine-d7

Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-96997
CAS No.
--
Molecular Formula
C30H49D7N6O10
Molecular Weight
667.84
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-96997
M.F.
C30H49D7N6O10
M.W.
667.84
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
N-Boc Deferoxamine-d7
References
"Inati, A. et al.: Am. J. Hematol., 85, 782 (2010); Selim, M.: Translat. Stroke Res., 1, 35 (2010); Cappellini, M.D. et al.: Hemoblobin, 33, 258 (2009)"
Synonyms
"t-Butyl (3,14,25-Trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25-pentaazatriacontan-30-yl)carbamate-d7"
Application Notes
"N-Boc Deferoxamine-d7 is an intermediate in synthesizing Deferoxamine-d7 TFA Salt (D228982), a labelled Deferoxamine Mesylate (D228980), which is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients."
Hazard Compound
Refer MSDS for complete information.
Overview
"N-Boc Deferoxamine-d7 is an intermediate in synthesizing Deferoxamine-d7 TFA Salt (D228982), a labelled Deferoxamine Mesylate (D228980), which is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients."

Customers Also Viewed

Methyl 2-Diethoxyphosphoryl-2-methoxyacetate-d10

Methyl 2-Diethoxyphosphoryl-2-methoxyacetate-d10

CAT No: CS-T-98829
 Tetracyanoquinodimethane-13C4

Tetracyanoquinodimethane-13C4

CAT No: CS-T-99813
 Benzo[a]pyrenetetrol II 1-d8

Benzo[a]pyrenetetrol II 1-d8

CAT No: CS-T-98255
 D-[1,1'-D2]glucitol

D-[1,1'-D2]glucitol

CAT No: CS-OC-00249
CAS No: 50-70-4 (unlabeled)
Raltegravir-d3 Potassium Salt

Raltegravir-d3 Potassium Salt

CAT No: CS-T-103275
CAS No: 1246816-98-7
Elinzanetant-d6

Elinzanetant-d6

CAT No: CS-O-59053
CAS No: 929046-33-3 (Unlabeled)
Rilpivirine-d6

Rilpivirine-d6

CAT No: CS-O-06927
CAS No: 1312424-26-2
Exemestane-16,16-D2

Exemestane-16,16-D2

CAT No: CS-SN-00091
CAS No: 107868-30-4 (Unlabelled)
Mono 3,3-Dimethyl-hept-2-yl Phthalate-d4

Mono 3,3-Dimethyl-hept-2-yl Phthalate-d4

CAT No: CS-T-98029
 Ospemifene-d4

Ospemifene-d4

CAT No: CS-O-14272
CAS No: 128607-22-7(Unlabeled)

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.